4//SEC Filing
DeLuca Richard R. 4
Accession 0001127602-23-027077
CIK 0000310158other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 9:04 AM ET
Size
6.1 KB
Accession
0001127602-23-027077
Insider Transaction Report
Form 4
DeLuca Richard R.
EVP&Pres, Merck Animal Health
Transactions
- Sale
Common Stock
2023-11-08$105.03/sh−43,823$4,602,668→ 111,763.592 total
Holdings
- 1,223.337(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.0000 to $105.0750, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- [F2]Holdings include shares acquired in dividend reinvestment transactions.
- [F3]Includes shares acquired and dividends earned through October 6, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001421339
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 9:04 AM ET
- Size
- 6.1 KB